Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 41 entries
Sorted by: Best Match Show Resources per page
Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study.

Pharmacy practice

Mobark DM, Al-Tabakha MM, Hasan S.
PMID: 31275503
Pharm Pract (Granada). 2019 Apr-Jun;17(2):1465. doi: 10.18549/PharmPract.2019.2.1465. Epub 2019 Jun 11.

BACKGROUND: Hormonal contraceptive pills have evolved as a common form of contraception worldwide. Pharmacists play a vital role in providing safe and effective access to these medicines. In many developing countries such as the United Arab Emirates (UAE), these...

Cite
Mobark DM, Al-Tabakha MM, Hasan S. Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study. Pharm Pract (Granada). 2019;17(2):1465doi: 10.18549/PharmPract.2019.2.1465.
Mobark, D. M., Al-Tabakha, M. M., & Hasan, S. (2019). Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study. Pharmacy practice, 17(2), 1465. https://doi.org/10.18549/PharmPract.2019.2.1465
Mobark, Dalal M, et al. "Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study." Pharmacy practice vol. 17,2 (2019): 1465. doi: https://doi.org/10.18549/PharmPract.2019.2.1465
Mobark DM, Al-Tabakha MM, Hasan S. Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study. Pharm Pract (Granada). 2019 Apr-Jun;17(2):1465. doi: 10.18549/PharmPract.2019.2.1465. Epub 2019 Jun 11. PMID: 31275503; PMCID: PMC6594436.
Copy Download .nbib Format: NLM
Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies.

JAMA network open

Brabaharan S, Veettil SK, Kaiser JE, Raja Rao VR, Wattanayingcharoenchai R, Maharajan M, Insin P, Talungchit P, Anothaisintawee T, Thakkinstian A, Chaiyakunapruk N.
PMID: 35029663
JAMA Netw Open. 2022 Jan 04;5(1):e2143730. doi: 10.1001/jamanetworkopen.2021.43730.

IMPORTANCE: Meta-analyses have reported conflicting data on the safety of hormonal contraception, but the quality of evidence for the associations between hormonal contraceptive use and adverse health outcomes has not been quantified in aggregate.OBJECTIVE: To grade the evidence from...

Cite
Brabaharan S, Veettil SK, Kaiser JE, et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022;5(1):e2143730doi: 10.1001/jamanetworkopen.2021.43730.
Brabaharan, S., Veettil, S. K., Kaiser, J. E., Raja Rao, V. R., Wattanayingcharoenchai, R., Maharajan, M., Insin, P., Talungchit, P., Anothaisintawee, T., Thakkinstian, A., & Chaiyakunapruk, N. (2022). Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA network open, 5(1), e2143730. https://doi.org/10.1001/jamanetworkopen.2021.43730
Brabaharan, Sharmila, et al. "Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies." JAMA network open vol. 5,1 (2022): e2143730. doi: https://doi.org/10.1001/jamanetworkopen.2021.43730
Brabaharan S, Veettil SK, Kaiser JE, Raja Rao VR, Wattanayingcharoenchai R, Maharajan M, Insin P, Talungchit P, Anothaisintawee T, Thakkinstian A, Chaiyakunapruk N. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022 Jan 04;5(1):e2143730. doi: 10.1001/jamanetworkopen.2021.43730. PMID: 35029663.
Copy Download .nbib Format: NLM
Contraception e-learning for medical students.

BMJ sexual & reproductive health

Douglass KM, Niino C, Bryan K, Kwan L, Sridhar A.
PMID: 34949689
BMJ Sex Reprod Health. 2021 Dec 23; doi: 10.1136/bmjsrh-2021-201401. Epub 2021 Dec 23.

No abstract available.

Cite
Douglass KM, Niino C, Bryan K, et al. Contraception e-learning for medical students. BMJ Sex Reprod Health. 2021;doi: 10.1136/bmjsrh-2021-201401.
Douglass, K. M., Niino, C., Bryan, K., Kwan, L., & Sridhar, A. (2021). Contraception e-learning for medical students. BMJ sexual & reproductive health, . https://doi.org/10.1136/bmjsrh-2021-201401
Douglass, Krista Marie, et al. "Contraception e-learning for medical students." BMJ sexual & reproductive health vol. (2021). doi: https://doi.org/10.1136/bmjsrh-2021-201401
Douglass KM, Niino C, Bryan K, Kwan L, Sridhar A. Contraception e-learning for medical students. BMJ Sex Reprod Health. 2021 Dec 23; doi: 10.1136/bmjsrh-2021-201401. Epub 2021 Dec 23. PMID: 34949689.
Copy Download .nbib Format: NLM
Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice.

Molecular biotechnology

Mehri N, Jamshidizad A, Ghanei Z, Karkhane AA, Shamsara M.
PMID: 34272681
Mol Biotechnol. 2021 Dec;63(12):1169-1182. doi: 10.1007/s12033-021-00369-w. Epub 2021 Jul 16.

Leukemia inhibitory factor (LIF) is an essential cytokine for blastocyst implantation. This study evaluated the effect of LIF inhibition on the blockage of embryo implantation. A truncated mouse LIF (tmLIF) was designed and expressed in E. coli. The protein...

Cite
Mehri N, Jamshidizad A, Ghanei Z, et al. Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice. Mol Biotechnol. 2021;63(12):1169-1182doi: 10.1007/s12033-021-00369-w.
Mehri, N., Jamshidizad, A., Ghanei, Z., Karkhane, A. A., & Shamsara, M. (2021). Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice. Molecular biotechnology, 63(12), 1169-1182. https://doi.org/10.1007/s12033-021-00369-w
Mehri, Nahid, et al. "Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice." Molecular biotechnology vol. 63,12 (2021): 1169-1182. doi: https://doi.org/10.1007/s12033-021-00369-w
Mehri N, Jamshidizad A, Ghanei Z, Karkhane AA, Shamsara M. Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice. Mol Biotechnol. 2021 Dec;63(12):1169-1182. doi: 10.1007/s12033-021-00369-w. Epub 2021 Jul 16. PMID: 34272681.
Copy Download .nbib Format: NLM
Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?.

Expert opinion on drug safety

de Jesus SM, Santana RS, Leite SN.
PMID: 34232089
Expert Opin Drug Saf. 2021 Jul 15;1-15. doi: 10.1080/14740338.2021.1953467. Epub 2021 Jul 15.

INTRODUCTION: One of the biggest drug disasters in history has not prevented thalidomide from being used to treat various clinical conditions. Currently, Brazil has a worrying scenario: high consumption of the drug and, cases of pregnant women using thalidomide,...

Cite
de Jesus SM, Santana RS, Leite SN. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opin Drug Saf. 2021;1-15doi: 10.1080/14740338.2021.1953467.
de Jesus, S. M., Santana, R. S., & Leite, S. N. (2021). Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert opinion on drug safety, 1-15. https://doi.org/10.1080/14740338.2021.1953467
de Jesus, Soraya Machado, et al. "Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?." Expert opinion on drug safety vol. (2021): 1-15. doi: https://doi.org/10.1080/14740338.2021.1953467
de Jesus SM, Santana RS, Leite SN. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opin Drug Saf. 2021 Jul 15;1-15. doi: 10.1080/14740338.2021.1953467. Epub 2021 Jul 15. PMID: 34232089.
Copy Download .nbib Format: NLM
Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK.

BMJ sexual & reproductive health

Atkinson M, James G, Bond K, Harcombe Z, Labrecque M.
PMID: 34321257
BMJ Sex Reprod Health. 2022 Jan;48(1):54-59. doi: 10.1136/bmjsrh-2021-201064. Epub 2021 Jul 28.

BACKGROUND: Vasectomy occlusive success is defined by the recommendation of 'clearance' to stop other contraception, and is elicited by post-vasectomy semen analysis (PVSA). We evaluated how the choice of either a postal or non-postal PVSA submission strategy was associated...

Cite
Atkinson M, James G, Bond K, et al. Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK. BMJ Sex Reprod Health. 2021;48(1):54-59doi: 10.1136/bmjsrh-2021-201064.
Atkinson, M., James, G., Bond, K., Harcombe, Z., & Labrecque, M. (2022). Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK. BMJ sexual & reproductive health, 48(1), 54-59. https://doi.org/10.1136/bmjsrh-2021-201064
Atkinson, Melanie, et al. "Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK." BMJ sexual & reproductive health vol. 48,1 (2022): 54-59. doi: https://doi.org/10.1136/bmjsrh-2021-201064
Atkinson M, James G, Bond K, Harcombe Z, Labrecque M. Comparison of postal and non-postal post-vasectomy semen sample submission strategies on compliance and failures: an 11-year analysis of the audit database of the Association of Surgeons in Primary Care of the UK. BMJ Sex Reprod Health. 2022 Jan;48(1):54-59. doi: 10.1136/bmjsrh-2021-201064. Epub 2021 Jul 28. PMID: 34321257.
Copy Download .nbib Format: NLM
Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).

International journal of women's health

Wieder DR, Pattimakiel L.
PMID: 21151688
Int J Womens Health. 2010 Nov 12;2:401-9. doi: 10.2147/IJWH.S6162.

The contraceptive vaginal ring is a novel contraceptive method that offers unique advantages. Intravaginal delivery of both estrogen and progesterone allows continuous release of medication, resulting in lower systemic levels. The use of long-term combined hormonal contraception enables improved...

Cite
Wieder DR, Pattimakiel L. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). Int J Womens Health. 2010;2:401-9doi: 10.2147/IJWH.S6162.
Wieder, D. R., & Pattimakiel, L. (2010). Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). International journal of women's health, 2401-9. https://doi.org/10.2147/IJWH.S6162
Wieder, Devorah R, and Pattimakiel, Lynn. "Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing)." International journal of women's health vol. 2 (2010): 401-9. doi: https://doi.org/10.2147/IJWH.S6162
Wieder DR, Pattimakiel L. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). Int J Womens Health. 2010 Nov 12;2:401-9. doi: 10.2147/IJWH.S6162. PMID: 21151688; PMCID: PMC2990910.
Copy Download .nbib Format: NLM
Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots.

Evidence-based complementary and alternative medicine : eCAM

Vasudeva N, Sharma SK.
PMID: 18317554
Evid Based Complement Alternat Med. 2008 Mar;5(1):91-4. doi: 10.1093/ecam/nem003.

Ancient literature mentions the use of a number of plants/preparations for fertility regulation. Some local contraceptive agents have also been described in Ayurvedic and Unani texts. Documented experiments or clinical data are, however, lacking. Therefore, the present study was...

Cite
Vasudeva N, Sharma SK. Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots. Evid Based Complement Alternat Med. 2008;5(1):91-4doi: 10.1093/ecam/nem003.
Vasudeva, N., & Sharma, S. K. (2008). Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots. Evidence-based complementary and alternative medicine : eCAM, 5(1), 91-4. https://doi.org/10.1093/ecam/nem003
Vasudeva, Neeru, and Sharma, S K. "Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots." Evidence-based complementary and alternative medicine : eCAM vol. 5,1 (2008): 91-4. doi: https://doi.org/10.1093/ecam/nem003
Vasudeva N, Sharma SK. Post-Coital Antifertility Activity of Hibiscus rosa-sinensis Linn. roots. Evid Based Complement Alternat Med. 2008 Mar;5(1):91-4. doi: 10.1093/ecam/nem003. PMID: 18317554; PMCID: PMC2249740.
Copy Download .nbib Format: NLM
Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood.

Korean journal of family medicine

Khafagy GM, Shalaby HL, Saad NE, Hasan MD.
PMID: 34871488
Korean J Fam Med. 2021 Nov;42(6):471-476. doi: 10.4082/kjfm.20.0106. Epub 2021 Nov 20.

BACKGROUND: Contraceptive agents are widely used by women of reproductive age, and resulting depression is the most common side effect of this usage. This study aimed to study the effect of monthly injectable combined contraceptives versus that of combined...

Cite
Khafagy GM, Shalaby HL, Saad NE, et al. Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood. Korean J Fam Med. 2021;42(6):471-476doi: 10.4082/kjfm.20.0106.
Khafagy, G. M., Shalaby, H. L., Saad, N. E., & Hasan, M. D. (2021). Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood. Korean journal of family medicine, 42(6), 471-476. https://doi.org/10.4082/kjfm.20.0106
Khafagy, Ghada M, et al. "Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood." Korean journal of family medicine vol. 42,6 (2021): 471-476. doi: https://doi.org/10.4082/kjfm.20.0106
Khafagy GM, Shalaby HL, Saad NE, Hasan MD. Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood. Korean J Fam Med. 2021 Nov;42(6):471-476. doi: 10.4082/kjfm.20.0106. Epub 2021 Nov 20. PMID: 34871488; PMCID: PMC8648491.
Copy Download .nbib Format: NLM
Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure.

Cureus

Chang AD, Lipman GS.
PMID: 32117662
Cureus. 2020 Jan 26;12(1):e6776. doi: 10.7759/cureus.6776.

Precipitous delivery in the emergency department is a high-acuity, low-occurrence event that requires rapid recognition and interdepartment cooperation to prevent fetal and maternal morbidity and mortality. Prompt recognition of the peripartum state can be delayed by reported usage of...

Cite
Chang AD, Lipman GS. Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure. Cureus. 2020;12(1):e6776doi: 10.7759/cureus.6776.
Chang, A. D., & Lipman, G. S. (2020). Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure. Cureus, 12(1), e6776. https://doi.org/10.7759/cureus.6776
Chang, Allen D, and Lipman, Grant S. "Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure." Cureus vol. 12,1 (2020): e6776. doi: https://doi.org/10.7759/cureus.6776
Chang AD, Lipman GS. Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure. Cureus. 2020 Jan 26;12(1):e6776. doi: 10.7759/cureus.6776. PMID: 32117662; PMCID: PMC7041648.
Copy Download .nbib Format: NLM
Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study.

BMJ sexual & reproductive health

Heller RL, Cameron S, Johnstone A, Cochrane R, Glasier A.
PMID: 34429350
BMJ Sex Reprod Health. 2022 Jan;48(1):69-70. doi: 10.1136/bmjsrh-2021-201184. Epub 2021 Aug 24.

No abstract available.

Cite
Heller RL, Cameron S, Johnstone A, et al. Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ Sex Reprod Health. 2021;48(1):69-70doi: 10.1136/bmjsrh-2021-201184.
Heller, R. L., Cameron, S., Johnstone, A., Cochrane, R., & Glasier, A. (2022). Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ sexual & reproductive health, 48(1), 69-70. https://doi.org/10.1136/bmjsrh-2021-201184
Heller, Rebecca L, et al. "Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study." BMJ sexual & reproductive health vol. 48,1 (2022): 69-70. doi: https://doi.org/10.1136/bmjsrh-2021-201184
Heller RL, Cameron S, Johnstone A, Cochrane R, Glasier A. Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ Sex Reprod Health. 2022 Jan;48(1):69-70. doi: 10.1136/bmjsrh-2021-201184. Epub 2021 Aug 24. PMID: 34429350.
Copy Download .nbib Format: NLM
Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.

Endocrinology, diabetes & metabolism

Carton T, Mathieu E, Wolff F, Bouziotis J, Corvilain B, Driessens N.
PMID: 34277979
Endocrinol Diabetes Metab. 2021 May 26;4(3):e00255. doi: 10.1002/edm2.255. eCollection 2021 Jul.

INTRODUCTION: Late-night salivary cortisol (LSaC) and 24-h urinary free cortisol measurement, and overnight 1-mg dexamethasone suppression test (1 mg-DST) are the first-line screening tests recommended for Cushing's syndrome. Through elevations in the level of cortisol-binding globulin, oral contraceptive agents...

Cite
Carton T, Mathieu E, Wolff F, et al. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives. Endocrinol Diabetes Metab. 2021;4(3):e00255doi: 10.1002/edm2.255.
Carton, T., Mathieu, E., Wolff, F., Bouziotis, J., Corvilain, B., & Driessens, N. (2021). Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives. Endocrinology, diabetes & metabolism, 4(3), e00255. https://doi.org/10.1002/edm2.255
Carton, Tiphaine, et al. "Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives." Endocrinology, diabetes & metabolism vol. 4,3 (2021): e00255. doi: https://doi.org/10.1002/edm2.255
Carton T, Mathieu E, Wolff F, Bouziotis J, Corvilain B, Driessens N. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives. Endocrinol Diabetes Metab. 2021 May 26;4(3):e00255. doi: 10.1002/edm2.255. eCollection 2021 Jul. PMID: 34277979; PMCID: PMC8279609.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 41 entries